Breaking News

FTC Approves Schering-Plough/Organon Deal

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Schering-Plough has received antitrust clearance from the U.S. Federal Trade Commission (FTC) regarding its acquisition of Organon BioSciences from Akzo Nobel. SP received approval from The European Commission on Oct. 11, 2007. Organon BioSciences is comprised mainly of Organon (human pharmaceuticals), Intervet (animal health), Nobilon (human vaccine development), and Diosynth (contract manufacturing). In connection with the conditional clearance, SP and Intervet will divest three poultry va...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters